Certain Liquid Transfer Devices With an Integral Vial Adapter; Institution of Investigation, 30342-30343 [2023-10078]

Download as PDF 30342 Federal Register / Vol. 88, No. 91 / Thursday, May 11, 2023 / Notices repatriation. Requests for joint repatriation of the human remains and associated funerary objects are considered a single request and not competing requests. UTK is responsible for sending a copy of this notice to the Indian Tribes identified in this notice. Authority: Native American Graves Protection and Repatriation Act, 25 U.S.C. 3003, and the implementing regulations, 43 CFR 10.9, 10.10, and 10.14. Dated: May 5, 2023. Melanie O’Brien, Manager, National NAGPRA Program. [FR Doc. 2023–10032 Filed 5–10–23; 8:45 am] BILLING CODE 4312–52–P INTERNATIONAL TRADE COMMISSION [Investigation No. 337–TA–1362] Certain Liquid Transfer Devices With an Integral Vial Adapter; Institution of Investigation U.S. International Trade Commission. ACTION: Notice. AGENCY: Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on April 6, 2023, under section 337 of the Tariff Act of 1930, as amended, on behalf of West Pharmaceutical Services, Inc. of Exton, Pennsylvania and West Pharma. Services IL, Ltd. of Ra′anana, Israel. A supplement to the complaint was filed on April 21, 2023. The complaint, as supplemented, alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain liquid transfer devices with an integral vial adapter by reason of the infringement of: (1) certain claims of U.S. Patent No. 10,688,295 (‘‘the ’295 patent’’); U.S. Design Patent No. D767,124 (‘‘the D’124 patent’’), U.S. Design Patent No. D765,837 (‘‘the D’837 patent’’), and U.S. Design Patent No. D630,732 (‘‘the D’732 patent’’); and (2) U.S. Trademark Registration No. 5,810,583 (‘‘the ’583 mark’’). The complaint further alleges that an industry in the United States exists or is in the process of being established as required by the applicable Federal Statute. The complainants request that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and cease and desist orders. ADDRESSES: The complaint, except for any confidential information contained ddrumheller on DSK120RN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 17:07 May 10, 2023 Jkt 259001 therein, may be viewed on the Commission’s electronic docket (EDIS) at https://edis.usitc.gov. For help accessing EDIS, please email EDIS3Help@usitc.gov. Hearing impaired individuals are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205–1810. Persons with mobility impairments who will need special assistance in gaining access to the Commission should contact the Office of the Secretary at (202) 205– 2000. General information concerning the Commission may also be obtained by accessing its internet server at https://www.usitc.gov. FOR FURTHER INFORMATION CONTACT: Pathenia M. Proctor, The Office of Unfair Import Investigations, telephone (202) 205–2560. SUPPLEMENTARY INFORMATION: Authority: The authority for institution of this investigation is contained in section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, and in section 210.10 of the Commission’s Rules of Practice and Procedure, 19 CFR 210.10 (2023). Scope of Investigation: Having considered the complaint, the U.S. International Trade Commission, on May 5, 2023, ordered that— (1) Pursuant to subsection (b) of section 337 of the Tariff Act of 1930, as amended, (a) an investigation be instituted to determine whether there is a violation of subsection (a)(1)(B) of section 337 in the importation into the United States, the sale for importation, or the sale within the United States after importation of certain products identified in paragraph (2) by reason of infringement of one or more of claim 1 of the ’295 patent; the claim of the D’124 patent; the claim of the D’837 patent; the claim of the D’732 patent, and whether an industry in the United States exists or is in the process of being established as required by subsection (a)(2) of section 337; and (b) an investigation be instituted to determine whether there is a violation of subsection (a)(1)(C) of section 337 in the importation into the United States, the sale for importation, or the sale within the United States after importation of certain products identified in paragraph (2) by reason of infringement of the ’583 mark, and whether an industry in the United States exists or is in the process of being established as required by subsection (a)(2) of section 337; (2) Pursuant to section 210.10(b)(1) of the Commission’s Rules of Practice and Procedure, 19 CFR 210.10(b)(1), the PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 plain language description of the accused products or category of accused products, which defines the scope of the investigation, is ‘‘liquid transfer devices that have a trifurcated connector body, with one end including an integral vial adapter, and wherein the integral vial adapter has a diameter of 13mm or 20mm and may only be used with a vial’’; (3) For the purpose of the investigation so instituted, the following are hereby named as parties upon which this notice of investigation shall be served: (a) The complainants are: West Pharmaceutical Services, Inc., 530 Herman O. West Drive, Exton, PA 19341, West Pharma. Services IL, Ltd., 4 Hasheizaf St., Ra′anana 4366411, Israel (b) The respondents are the following entities alleged to be in violation of section 337, and are the parties upon which the complaint is to be served: Advcare Medical, Inc., No. 36, Sinsing St., Shulin District, New Taipei City, Taiwan 23877 Dragon Heart Medical Devices Co., Ltd., 28 Ruliang Road, Baihe Town, Kaiping City, Guangdong Province, China 529375 Dragon Heart Medical, Inc., 901 South Rohlwing Rd., Unit H, Addison, IL 60101 Summit International Medical, Technologies, Inc., 101 Constitution Blvd., Franklin, MA 02038 (c) The Office of Unfair Import Investigations, U.S. International Trade Commission, 500 E Street SW, Suite 401, Washington, DC 20436; and (4) For the investigation so instituted, the Chief Administrative Law Judge, U.S. International Trade Commission, shall designate the presiding Administrative Law Judge. Responses to the complaint and the notice of investigation must be submitted by the named respondents in accordance with section 210.13 of the Commission’s Rules of Practice and Procedure, 19 CFR 210.13. Pursuant to 19 CFR 201.16(e) and 210.13(a), as amended in 85 FR 15798 (March 19, 2020), such responses will be considered by the Commission if received not later than 20 days after the date of service by the complainants of the complaint and the notice of investigation. Extensions of time for submitting responses to the complaint and the notice of investigation will not be granted unless good cause therefor is shown. Failure of a respondent to file a timely response to each allegation in the complaint and in this notice may be E:\FR\FM\11MYN1.SGM 11MYN1 Federal Register / Vol. 88, No. 91 / Thursday, May 11, 2023 / Notices deemed to constitute a waiver of the right to appear and contest the allegations of the complaint and this notice, and to authorize the administrative law judge and the Commission, without further notice to the respondent, to find the facts to be as alleged in the complaint and this notice and to enter an initial determination and a final determination containing such findings, and may result in the issuance of an exclusion order or a cease and desist order or both directed against the respondent. By order of the Commission. Issued: May 8, 2023. Lisa Barton, Secretary to the Commission. [FR Doc. 2023–10078 Filed 5–10–23; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Federal Bureau of Investigation Meeting of the CJIS Advisory Policy Board Federal Bureau of Investigation, Department of Justice. ACTION: Meeting notice. AGENCY: The purpose of this notice is to announce a meeting of the Federal Bureau of Investigation’s (FBI) Criminal Justice Information Services (CJIS) Advisory Policy Board (APB). The CJIS APB is a federal advisory committee established pursuant to the Federal Advisory Committee Act (FACA). This meeting announcement is being published as required by Section 10 of the FACA. DATES: The APB will meet in open session from 8:30 a.m. until 6:00 p.m. on June 7–8, 2023. ADDRESSES: The meeting will take place at the Renaissance Phoenix Glendale Hotel & Spa, 9495 Entertainment Boulevard, Glendale, AZ 85305; telephone: 623–937–3700. Due to COVID–19 safety precautions limit meeting space accommodations the CJIS Division is offering a blended participation option that allows for a limited number of individuals to participate in person and additional individuals to participate via a telephone bridge line. The public will be permitted to provide comments and/ or questions related to matters of the APB prior to the meeting. In-person gallery participation will be limited to the first 140 external participants who register to attend in person. Additional participants may also participate via a ddrumheller on DSK120RN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 17:07 May 10, 2023 Jkt 259001 30343 telephone bridge line. Please see details in the supplemental information. minutes for the meeting published on the FACA website. FOR FURTHER INFORMATION CONTACT: Nicky J. Megna, CJIS Designated Federal Officer, Criminal Justice Information, Services Division, Federal Bureau of Investigation. Inquiries may be addressed to Ms. Melissa Abel, Management and Program Analyst, Advisory Process Management Office, Law Enforcement Support Section; 1000 Custer Hollow Road, Clarksburg, West Virginia 26306; email: agmu@leo.gov; telephone: 304–625– 5670. The FBI CJIS APB is responsible for reviewing policy issues and appropriate technical and operational issues related to the programs administered by the FBI’s CJIS Division, and thereafter, making appropriate recommendations to the FBI Director. The programs administered by the CJIS Division are the Law Enforcement Enterprise Portal, National Crime Information Center, Next Generation Identification, National Instant Criminal Background Check System, National Data Exchange System, and Uniform Crime Reporting. The meeting will be conducted with a blended participation option. The public may participate as follows: Public registrations will be processed on a first-come, first-served basis. The first 140 individuals to register will be afforded the opportunity to participate in person and are required to check-in at the meeting registration desk. Any additional registrants will be provided with a phone bridge number to participate in a listen-only mode. Registrations will be taken via email to agmu@leo.gov. Information regarding the phone access will be provided prior to the meeting to all registered individuals. Interested persons whose registrations have been accepted may be permitted to participate in the discussions at the discretion of the meeting chairman and with approval of the Designated Federal Officer (DFO). Any member of the public may file a written statement with the APB. Written comments shall be focused on the APB’s issues under discussion and may not be repetitive of previously submitted written statements. Written comments should be provided to Mr. Nicky J. Megna, DFO, at least seven (7) days in advance of the meeting so the comments may be made available to the APB members for their consideration prior to the meeting. Individuals requiring special accommodations should contact Mr. Megna by no later than May 30, 2023. Personal registration information will be made publicly available through the SUPPLEMENTARY INFORMATION: PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 [FR Doc. 2023–10039 Filed 5–10–23; 8:45 am] BILLING CODE 4410–02–P DEPARTMENT OF LABOR Employment and Training Administration Notice of Intent To Renew the Advisory Committee on Apprenticeship (ACA) Charter Employment and Training Administration (ETA), Labor. ACTION: Notice. AGENCY: The Secretary of Labor (Secretary) has determined that the renewal of the Advisory Committee on Apprenticeship (ACA or Committee) is necessary and in the public interest. The Department of Labor (DOL) intends to renew the ACA charter with revisions which are not intended to change the Committee’s purpose or original intent. The revisions update the charter to ensure its closer alignment with the Department’s current apprenticeship priorities. DATES: The renewed ACA charter will be filed after this notice publishes. FOR FURTHER INFORMATION CONTACT: For any questions concerning the Charter renewal, please contact John Ladd, OA Administrator and ACA DFO, at advisorycommitteeonapprenticeship@ dol.gov, telephone (202) 693–2796 (this is not a toll-free number). SUPPLEMENTARY INFORMATION: Registered Apprenticeship is a unique public private partnership that is highly dependent on the engagement and involvement of its stakeholders and partners for its ongoing operational effectiveness. Apart from the ACA, there is no single organization or group with the broad representation of labor, employers, and the public available to consider the complexities and relationship of apprenticeship activities to other training efforts or to provide advice on such matters to the Secretary. It is particularly important to have such perspectives as DOL considers the expansion of registered apprenticeship, fundamentally instilling a permanent culture of inclusion in our workforce. The ACA’s insight and recommendations on the best ways to address critical apprenticeship issues to meet the emerging needs of industry, SUMMARY: E:\FR\FM\11MYN1.SGM 11MYN1

Agencies

INTERNATIONAL TRADE COMMISSION

[Federal Register Volume 88, Number 91 (Thursday, May 11, 2023)]
[Notices]
[Pages 30342-30343]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-10078]


=======================================================================
-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 337-TA-1362]


Certain Liquid Transfer Devices With an Integral Vial Adapter; 
Institution of Investigation

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that a complaint was filed with the 
U.S. International Trade Commission on April 6, 2023, under section 337 
of the Tariff Act of 1930, as amended, on behalf of West Pharmaceutical 
Services, Inc. of Exton, Pennsylvania and West Pharma. Services IL, 
Ltd. of Ra'anana, Israel. A supplement to the complaint was filed on 
April 21, 2023. The complaint, as supplemented, alleges violations of 
section 337 based upon the importation into the United States, the sale 
for importation, and the sale within the United States after 
importation of certain liquid transfer devices with an integral vial 
adapter by reason of the infringement of: (1) certain claims of U.S. 
Patent No. 10,688,295 (``the '295 patent''); U.S. Design Patent No. 
D767,124 (``the D'124 patent''), U.S. Design Patent No. D765,837 (``the 
D'837 patent''), and U.S. Design Patent No. D630,732 (``the D'732 
patent''); and (2) U.S. Trademark Registration No. 5,810,583 (``the 
'583 mark''). The complaint further alleges that an industry in the 
United States exists or is in the process of being established as 
required by the applicable Federal Statute. The complainants request 
that the Commission institute an investigation and, after the 
investigation, issue a limited exclusion order and cease and desist 
orders.

ADDRESSES: The complaint, except for any confidential information 
contained therein, may be viewed on the Commission's electronic docket 
(EDIS) at https://edis.usitc.gov. For help accessing EDIS, please email 
[email protected]. Hearing impaired individuals are advised that 
information on this matter can be obtained by contacting the 
Commission's TDD terminal on (202) 205-1810. Persons with mobility 
impairments who will need special assistance in gaining access to the 
Commission should contact the Office of the Secretary at (202) 205-
2000. General information concerning the Commission may also be 
obtained by accessing its internet server at https://www.usitc.gov.

FOR FURTHER INFORMATION CONTACT: Pathenia M. Proctor, The Office of 
Unfair Import Investigations, telephone (202) 205-2560.

SUPPLEMENTARY INFORMATION: 
    Authority: The authority for institution of this investigation is 
contained in section 337 of the Tariff Act of 1930, as amended, 19 
U.S.C. 1337, and in section 210.10 of the Commission's Rules of 
Practice and Procedure, 19 CFR 210.10 (2023).
    Scope of Investigation: Having considered the complaint, the U.S. 
International Trade Commission, on May 5, 2023, ordered that--
    (1) Pursuant to subsection (b) of section 337 of the Tariff Act of 
1930, as amended,
    (a) an investigation be instituted to determine whether there is a 
violation of subsection (a)(1)(B) of section 337 in the importation 
into the United States, the sale for importation, or the sale within 
the United States after importation of certain products identified in 
paragraph (2) by reason of infringement of one or more of claim 1 of 
the '295 patent; the claim of the D'124 patent; the claim of the D'837 
patent; the claim of the D'732 patent, and whether an industry in the 
United States exists or is in the process of being established as 
required by subsection (a)(2) of section 337; and
    (b) an investigation be instituted to determine whether there is a 
violation of subsection (a)(1)(C) of section 337 in the importation 
into the United States, the sale for importation, or the sale within 
the United States after importation of certain products identified in 
paragraph (2) by reason of infringement of the '583 mark, and whether 
an industry in the United States exists or is in the process of being 
established as required by subsection (a)(2) of section 337;
    (2) Pursuant to section 210.10(b)(1) of the Commission's Rules of 
Practice and Procedure, 19 CFR 210.10(b)(1), the plain language 
description of the accused products or category of accused products, 
which defines the scope of the investigation, is ``liquid transfer 
devices that have a trifurcated connector body, with one end including 
an integral vial adapter, and wherein the integral vial adapter has a 
diameter of 13mm or 20mm and may only be used with a vial'';
    (3) For the purpose of the investigation so instituted, the 
following are hereby named as parties upon which this notice of 
investigation shall be served:
    (a) The complainants are:

West Pharmaceutical Services, Inc., 530 Herman O. West Drive, Exton, PA 
19341, West Pharma. Services IL, Ltd., 4 Hasheizaf St., Ra'anana 
4366411, Israel

    (b) The respondents are the following entities alleged to be in 
violation of section 337, and are the parties upon which the complaint 
is to be served:

Advcare Medical, Inc., No. 36, Sinsing St., Shulin District, New Taipei 
City, Taiwan 23877
Dragon Heart Medical Devices Co., Ltd., 28 Ruliang Road, Baihe Town, 
Kaiping City, Guangdong Province, China 529375
Dragon Heart Medical, Inc., 901 South Rohlwing Rd., Unit H, Addison, IL 
60101
Summit International Medical, Technologies, Inc., 101 Constitution 
Blvd., Franklin, MA 02038

    (c) The Office of Unfair Import Investigations, U.S. International 
Trade Commission, 500 E Street SW, Suite 401, Washington, DC 20436; and
    (4) For the investigation so instituted, the Chief Administrative 
Law Judge, U.S. International Trade Commission, shall designate the 
presiding Administrative Law Judge.
    Responses to the complaint and the notice of investigation must be 
submitted by the named respondents in accordance with section 210.13 of 
the Commission's Rules of Practice and Procedure, 19 CFR 210.13. 
Pursuant to 19 CFR 201.16(e) and 210.13(a), as amended in 85 FR 15798 
(March 19, 2020), such responses will be considered by the Commission 
if received not later than 20 days after the date of service by the 
complainants of the complaint and the notice of investigation. 
Extensions of time for submitting responses to the complaint and the 
notice of investigation will not be granted unless good cause therefor 
is shown.
    Failure of a respondent to file a timely response to each 
allegation in the complaint and in this notice may be

[[Page 30343]]

deemed to constitute a waiver of the right to appear and contest the 
allegations of the complaint and this notice, and to authorize the 
administrative law judge and the Commission, without further notice to 
the respondent, to find the facts to be as alleged in the complaint and 
this notice and to enter an initial determination and a final 
determination containing such findings, and may result in the issuance 
of an exclusion order or a cease and desist order or both directed 
against the respondent.

    By order of the Commission.

    Issued: May 8, 2023.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2023-10078 Filed 5-10-23; 8:45 am]
BILLING CODE 7020-02-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.